Thyrocare Technologies Ltd on Friday said that its promoter Docon Technologies Pvt Ltd sold about 10 percent of the company’s equity stake in open market transactions for Rs 667.69 crore.
Docon sold 53.33 lakh shares of Thyrocare on October 24 at an average price of about Rs 1,252.03 per share, according to a disclosure made by the company to the exchanges. Following the sale, Docon’s shareholding in Thyrocare has fallen to 60.93 percent from 70.98 percent earlier. The company clarified that Docon continues to remain a promoter even after this transaction.
Thyrocare stock rose 1.62 percent to Rs 1,272.20 on Friday, valuing the diagnostics chain at about Rs 6,700 crore. The stock has gained over 50 percent in the past six months and trades near the upper end of its 52-week range of Rs 658 to Rs 1,474.
The deal was executed through market trades and will be settled as per applicable regulations, Thyrocare said in its filing.
Earlier this month, Thyrocare Technologies reported a strong financial performance for Q2 FY26, with net profit surging 80 percent year-on-year to Rs 48 crore, compared with Rs 27 crore in the same period last year. Revenue from operations rose over 22 percent to Rs 216.53 crore, while consolidated EBITDA climbed 48 percent, with margins at 33 percent. The diagnostics chain also announced a 2:1 bonus issue of shares alongside its quarterly results.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before making any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
